Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;12(2):343-365.
doi: 10.1007/s40121-022-00750-5. Epub 2023 Jan 7.

Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review

Tanner M Johnson  1 , Thomas F Byrd  2 , Wendi K Drummond  3 , Lindsey M Childs-Kean  4 , Monica V Mahoney  5 , Jeffrey C Pearson  6 , Christina G Rivera  7
Affiliations
Review

Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review

Tanner M Johnson et al. Infect Dis Ther. 2023 Feb.

Abstract

Nontuberculous mycobacteria (NTM) are a group of atypical bacteria that may cause a spectrum of clinical manifestations, including pulmonary, musculoskeletal, skin and soft tissue, and cardiac infections. Antimycobacterial medication regimens for NTM infections require multiple agents with prolonged treatment courses and are often associated with poor tolerance in patients and suboptimal clinical outcomes. This review summarizes NTM pharmacotherapy, including treatment concepts, preferred medication regimens according to NTM species and site of infection, and emerging treatment methods for difficult-to-treat species.

Keywords: Antimycobacterials; Clofazimine; Mycobacterial infections; Mycobacterium abscessus; Mycobacterium avium complex; Nontuberculous; Nontuberculous mycobacteria; Omadacycline; Tedizolid; β-lactam/β-lactamase inhibitors.

PubMed Disclaimer

References

    1. Griffith DE, Aksamit TR. Managing Mycobacterium avium complex lung disease with a little help from my friend. Chest. 2021;159(4):1372–1381. doi: 10.1016/j.chest.2020.10.031. - DOI - PubMed
    1. Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977–982. doi: 10.1164/rccm.201003-0503OC. - DOI - PubMed
    1. Chan ED, Iseman MD. Underlying host risk factors for nontuberculous mycobacterial lung disease. Semin Respir Crit Care Med. 2013;34(1):110–123. doi: 10.1055/s-0033-1333573. - DOI - PubMed
    1. Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett. 1994;123(1–2):11–18. doi: 10.1111/j.1574-6968.1994.tb07194.x. - DOI - PubMed
    1. Falkinham JO. Growth in catheter biofilms and antibiotic resistance of Mycobacterium avium. J Med Microbiol. 2007;56(Pt 2):250–254. doi: 10.1099/jmm.0.46935-0. - DOI - PubMed

LinkOut - more resources